Upload
aidan-dillon
View
249
Download
1
Tags:
Embed Size (px)
Citation preview
Principles of Pharmacokinetics
Pharmacokinetics of IV Administration, 1-Compartment
Principles of Pharmacokinetics
Pharmacokinetics of IV Administration, 1-Compartment
Karunya Kandimalla, Ph.D.Associate Professor, Pharmaceutics
Karunya Kandimalla, Ph.D.Associate Professor, Pharmaceutics
2
Pharmacokinetics & PharmacodynamicsPharmacokinetics & Pharmacodynamics
Target organ
Target organ
RR
RR
RR
RR
RR
RR
ADME
3
Kinetics From the Blood or Plasma DataKinetics From the Blood or Plasma Data
Pharmacokinetics of a drug in plasma or blood
Pharmacokinetics of a drug in plasma or blood
Absorption (Input)Absorption (Input) DispositionDisposition
DistributionDistribution EliminationElimination
ExcretionExcretion MetabolismMetabolism
4
ObjectivesObjectives
• Be able to:• To understand the properties of linear models
• To understand assumptions associated with first order kinetics and one compartment models
• To define and calculate various one compartment model parameters (kel, t½, Vd, AUC and clearance)
• To estimate the values of kel, t½, Vd, AUC and clearance from plasma or blood concentrations of a drug following intravenous administration.
• Be able to:• To understand the properties of linear models
• To understand assumptions associated with first order kinetics and one compartment models
• To define and calculate various one compartment model parameters (kel, t½, Vd, AUC and clearance)
• To estimate the values of kel, t½, Vd, AUC and clearance from plasma or blood concentrations of a drug following intravenous administration.
5
Recommended ReadingsRecommended Readings
• Chapter 3, p. 47-62• IV route of administration
• Elimination rate constant
• Apparent volume of distribution
• Clearance
• Chapter 3, p. 47-62• IV route of administration
• Elimination rate constant
• Apparent volume of distribution
• Clearance
6
Intravascular AdministrationIntravascular Administration
• IV administration (bolus or infusion):
• Drugs are injected directly into central compartment (plasma, highly perfused organs, extracellular water)
• No passage across membranes
• Population or individual elimination rate constants (kel) and volumes of distribution (Vd) enable us to calculate doses or infusion rates that produce target (desired) concentrations
• IV administration (bolus or infusion):
• Drugs are injected directly into central compartment (plasma, highly perfused organs, extracellular water)
• No passage across membranes
• Population or individual elimination rate constants (kel) and volumes of distribution (Vd) enable us to calculate doses or infusion rates that produce target (desired) concentrations
7
Disposition Analysis (Dose Linearity)Disposition Analysis (Dose Linearity)
8
Disposition Analysis (Time Variance)Disposition Analysis (Time Variance)
0
5
10
15
20
25
30
35
40
0 5 10 15 20
Time (hr)
Pla
sm
a c
on
ce
ntr
atio
n (m g
/ml)
1st Adminitration
2nd Administration
3rd Administration
9
Linear DispositionLinear Disposition
• The disposition of a drug molecule is not affected by the presence of the other drug molecules
• Demonstrated by:a) Dose linearity
Saturable hepatic metabolism may result in deviations from the dose linearity
b) Time invariance
Influence of the drug on its own metabolism and excretion may cause time variance
• The disposition of a drug molecule is not affected by the presence of the other drug molecules
• Demonstrated by:a) Dose linearity
Saturable hepatic metabolism may result in deviations from the dose linearity
b) Time invariance
Influence of the drug on its own metabolism and excretion may cause time variance
10
Disposition ModelingDisposition Modeling
• A fit adequately describes the experimental data
• A model not only describes the experimental data but also makes extrapolations possible from the experimental data
• A fit that passes the tests of linearity will be qualified as a model
• A fit adequately describes the experimental data
• A model not only describes the experimental data but also makes extrapolations possible from the experimental data
• A fit that passes the tests of linearity will be qualified as a model
11
One Compartment Model (IV Bolus)One Compartment Model (IV Bolus)
• Schematically, one compartment model can be represented as:
Where Xp is the amount of drug in the body, Vd is the volume in which the drug distributes and kel is the first order elimination rate constant
• Schematically, one compartment model can be represented as:
Where Xp is the amount of drug in the body, Vd is the volume in which the drug distributes and kel is the first order elimination rate constant
Drug in Body
Drug in Body
Drug Eliminated
Drug Eliminated
Xp = Vd • C
kel
12
One Compartment Data (Linear Plot)One Compartment Data (Linear Plot)
0
5
10
15
20
25
30
35
0 5 10 15 20
Time (hr)
Pla
sm
a c
on
ce
ntr
atio
n (m g
/ml)
13
One Compartment Data (Semi-log Plot)One Compartment Data (Semi-log Plot)
0.1
1
10
100
0 5 10 15 20
Time (hr)
Pla
sm
a c
on
ce
ntr
atio
n (m g
/ml)
14
Two Compartment Model (IV Bolus)Two Compartment Model (IV Bolus)
• For both 1- and 2-compartment models, elimination takes place from central compartment
• For both 1- and 2-compartment models, elimination takes place from central compartment
Drug in Central
Compartment
Drug in Central
Compartment
Drug Eliminated
Drug Eliminated
Drug in Peripheral
Compartment
Drug in Peripheral
Compartment
kel
Blood, kidneys,
liver
Fat, muscle
K 12
K 21
15
Two Compartment Data (Linear Plot)Two Compartment Data (Linear Plot)
0
2
4
6
8
10
12
14
16
18
0 5 10 15
Time (hr)
Pla
sm
a c
on
ce
ntr
atio
n (m g
/ml)
16
Two Compartment Data (Semi-log Plot)Two Compartment Data (Semi-log Plot)
0.1
1
10
100
0 5 10 15
Time (hr)
Pla
sm
a c
on
ce
ntr
atio
n (m g
/ml)
17
One Compartment Model-AssumptionsOne Compartment Model-Assumptions
• 1-Compartment—Intravascular drug is in rapid equilibrium with extravascular drug• Intravascular drug [C] proportional to
extravascular [C]
• Rapid Mixing—Drug mixes rapidly in blood and plasma
• First Order Elimination Kinetics:• Rate of change of [C] Remaining [C]
• 1-Compartment—Intravascular drug is in rapid equilibrium with extravascular drug• Intravascular drug [C] proportional to
extravascular [C]
• Rapid Mixing—Drug mixes rapidly in blood and plasma
• First Order Elimination Kinetics:• Rate of change of [C] Remaining [C]
18
Derivation-One Compartment ModelDerivation-One Compartment Model
Bolus IV KelCentral Compartment (C)
303.2loglog
lnln
equation above thegLinearizin
tat time and 0 tat time
between equation above thegIntegratin
0
0
0
0
tKCC
tKCC
tKeCC
CC
dtKC
dC
CKdt
dC
el
el
el
el
el
303.2loglog
lnln
equation above thegLinearizin
tat time and 0 tat time
between equation above thegIntegratin
0
0
0
0
tKCC
tKCC
tKeCC
CC
dtKC
dC
CKdt
dC
el
el
el
el
el
19
IV Bolus Injection: Graphical Representation Assuming 1st Order KineticsIV Bolus Injection: Graphical Representation Assuming 1st Order Kinetics
• C0 = Initial [C]
• C0 is calculated by back-extrapolating the terminal elimination phase to time = 0
• C0 = Initial [C]
• C0 is calculated by back-extrapolating the terminal elimination phase to time = 0
C0 = Dose/Vd C0 = Dose/Vd
Slope = -K/2.303Slope = -Kel/2.303
Concentration versus time, semilog paper
20
Elimination Rate Constant (Kel)Elimination Rate Constant (Kel)
• Kel is the first order rate constant describing drug elimination (metabolism + excretion) from the body
• Kel is the proportionality constant relating the rate of change of drug concentration and the concentration
• The units of Kel are time-1, for example hr-1, min-1 or day-1
• Kel is the first order rate constant describing drug elimination (metabolism + excretion) from the body
• Kel is the proportionality constant relating the rate of change of drug concentration and the concentration
• The units of Kel are time-1, for example hr-1, min-1 or day-1
CKdt
dCel CK
dt
dCel
21
Half-Life (t1/2)Half-Life (t1/2)
//2/1
2/1
2/10
0
693.02ln
2/12
1ln
2
12
ee
el
el
el
KKt
tK
tKe
tKeCC
//2/1
2/1
2/10
0
693.02ln
2/12
1ln
2
12
ee
el
el
el
KKt
tK
tKe
tKeCC
• Time taken for the plasma concentration to reduce to half its original concentration
• Drug with low half-life is quickly eliminated from the body
• Time taken for the plasma concentration to reduce to half its original concentration
• Drug with low half-life is quickly eliminated from the body
t/t1/2% drug
remaining
1 50
2 25
3 12.5
4 6.25
5 3.125
22
Change in Drug Concentration as a Function of Half-LifeChange in Drug Concentration as a Function of Half-Life
0
20
40
60
80
100
120
t = 0 1 2 3 4 5 6 7
Number of Half-Lives
Pe
rce
nt
of
Dru
g R
em
ain
ing
% Remaining
23
Apparent Volume of Distribution (Vd)Apparent Volume of Distribution (Vd)
• Vd is not a physiological volume
• Vd is not lower than blood or plasma volume but for some drugs it can be much larger than body volume
• Drug with large Vd is extensively distributed to tissues
• Vd is expressed in liters and is calculated as:
• Distribution equilibrium between drug in tissues to that in plasma should be achieved to calculate Vd
• Vd is not a physiological volume
• Vd is not lower than blood or plasma volume but for some drugs it can be much larger than body volume
• Drug with large Vd is extensively distributed to tissues
• Vd is expressed in liters and is calculated as:
• Distribution equilibrium between drug in tissues to that in plasma should be achieved to calculate Vd
0
DoseV
C
0
DoseV
C
24
Volume of Distribution—The ConceptVolume of Distribution—The Concept
•• •• ••
•• •• ••
• • • • • •
• • • • • •
• •
•
• • •
Plasma [C] Tissue [C] “Apparent” Vd
• • • • •• • • • •
• • • • •• • • • • •
• • • • •• • • •
• • •
• • •
• • •
• • •
NB: For lipid-soluble drugs, Vd changes with body size and age (decreased lean body mass, increased fat)
25
Area Under the Curve (AUC)Area Under the Curve (AUC)
• AUC is not a parameter; changes with Dose
• Toxicology: AUC is used as a measure of drug exposure
• Pharmacokinetics: AUC is used as a measure of bioavailability and bioequivalence•Bioavailability: criterion of clinical effectiveness
•Bioequivalence: relative efficacy of different drug products (e.g. generic vs. brand name products)
• AUC has units of concentration time (mg.hr/L)
• AUC is not a parameter; changes with Dose
• Toxicology: AUC is used as a measure of drug exposure
• Pharmacokinetics: AUC is used as a measure of bioavailability and bioequivalence•Bioavailability: criterion of clinical effectiveness
•Bioequivalence: relative efficacy of different drug products (e.g. generic vs. brand name products)
• AUC has units of concentration time (mg.hr/L)
elK V
Dose
Clearance
DoseAUC
d
elK V
Dose
Clearance
DoseAUC
d
26
CC
tt
1
2
1
2
Concentration
Time
))(( 2112212
1CCttArea
t
t
))((
...))(())((
1121
233221
122121
0
nnnn
t
ttCC
ttCCttCCArea n
Calculation of AUC using trapezoidal ruleCalculation of AUC using trapezoidal rule
27
Clearance (Cl)Clearance (Cl)
• The most important disposition parameter that describes how quickly drugs are eliminated, metabolized and distributed in the body
• Clearance is not the elimination rate
• Has the units of flow rate (volume / time)
• Clearance can be related to renal or hepatic function
• Large clearance will result in low AUC
• The most important disposition parameter that describes how quickly drugs are eliminated, metabolized and distributed in the body
• Clearance is not the elimination rate
• Has the units of flow rate (volume / time)
• Clearance can be related to renal or hepatic function
• Large clearance will result in low AUC
AUC
DoseCl AUC
DoseCl
28
ORGANCinitial Cfinal
elimination
If Cfinal < Cinitial, then it is a clearing organ
Clearance -The ConceptClearance -The Concept
29
Practical ExamplePractical Example
• IV bolus administration
• Dose = 500 mg
• Drug has a linear disposition
• IV bolus administration
• Dose = 500 mg
• Drug has a linear disposition
Time (hr)
Plasma Conc. (mg/L)
ln (PlasmaConc.)
1 9.46 2.25
2 7.15 1.97
3 5.56 1.71
4 4.74 1.56
6 3.01 1.10
10 1.26 0.23
12 0.83 -0.19
30
Linear PlotLinear Plot
0
1
2
3
4
5
6
7
8
9
10
0 2 4 6 8 10 12
Time (hr)
Pla
sm
a c
on
ce
ntr
atio
n (
mg
/L)
31
Natural logarithm PlotNatural logarithm Plot
y = -0.218x + 2.4155
R2 = 0.9988
-0.5
0
0.5
1
1.5
2
2.5
0 2 4 6 8 10 12
Time (hr)
Ln
(P
lasm
a c
on
ce
ntr
atio
n) Kel ln (C0)
32
Half-Life and Volume of DistributionHalf-Life and Volume of Distribution
t1/2 = 0.693 / Kel = 3.172 hrs
Vd = Dose / C0 = 500 / 11.12 = 44.66
ln (C0) = 2.4155
C0 = Inv ln (2.4155) = 11.195 mg/L
t1/2 = 0.693 / Kel = 3.172 hrs
Vd = Dose / C0 = 500 / 11.12 = 44.66
ln (C0) = 2.4155
C0 = Inv ln (2.4155) = 11.195 mg/L
33
ClearanceClearance
Cl = D/AUC
Cl = VdKel
Cl = 44.66 0.218 = 9.73 L/hr
Cl = D/AUC
Cl = VdKel
Cl = 44.66 0.218 = 9.73 L/hr
34
Home WorkHome Work
Determine AUC and
Calculate clearance from AUC
Determine AUC and
Calculate clearance from AUC
Principles of Pharmacokinetics
Pharmacokinetics of IV Administration, 2-Compartment
Principles of Pharmacokinetics
Pharmacokinetics of IV Administration, 2-Compartment
Karunya Kandimalla, [email protected]
Karunya Kandimalla, [email protected]
36
ObjectivesObjectives
• Be able to:• Describe assumptions associated with multi-
compartment models
• Describe processes that take place during distribution and terminal elimination
• Define and calculate , β, t½, Vi, VdSS, Cl and
AUC
• Understand influence of Volume of distribution on loading doses and toxicity
• Design appropriate experiments to determine proper modeling of drug disposition
• Be able to:• Describe assumptions associated with multi-
compartment models
• Describe processes that take place during distribution and terminal elimination
• Define and calculate , β, t½, Vi, VdSS, Cl and
AUC
• Understand influence of Volume of distribution on loading doses and toxicity
• Design appropriate experiments to determine proper modeling of drug disposition
37
Recommended ReadingsRecommended Readings
• Chapter 4, p. 73-92, 95-97• Multicompartment model assumptions (73-4)
• Two-compartment open model (75-9)
• Method of residuals (79-81)
• Digoxin simulation (81-84)
• Apparent volume of distribution (84-90)
• Drug in tissue compartment (90-91)
• Clearance and elimination constant (92)
• Determination of compartment models (95-7)
• Chapter 4, p. 73-92, 95-97• Multicompartment model assumptions (73-4)
• Two-compartment open model (75-9)
• Method of residuals (79-81)
• Digoxin simulation (81-84)
• Apparent volume of distribution (84-90)
• Drug in tissue compartment (90-91)
• Clearance and elimination constant (92)
• Determination of compartment models (95-7)
38
Physiological PerspectivePhysiological Perspective
Onecompartment
Twocompartments
k12
Quick
Quick Slow
39
Notes on Two-Compartment ModelingNotes on Two-Compartment Modeling
Blood or Plasma Pharmacokinetics
(2 compartment model) Blood or Plasma Pharmacokinetics
(2 compartment model)
Absorption (Input)Absorption (Input) DispositionDisposition
• Ideal model should mimic distribution and disposition
• Full set of rate processes seldom taken into account
• Tissue [C] often unknown
• Because tissue [C] correlates with plasma [C], response often (but not always) correlates with plasma [C]
• Invasive nature of tissue sampling limits sophistication
• Ideal model should mimic distribution and disposition
• Full set of rate processes seldom taken into account
• Tissue [C] often unknown
• Because tissue [C] correlates with plasma [C], response often (but not always) correlates with plasma [C]
• Invasive nature of tissue sampling limits sophistication
DistributionDistributionDistributionDistribution EliminationElimination
ExcretionExcretion MetabolismMetabolism
40
Vi Vt
ViVt3
Vt2
k12
k21
k12
k21
k31
k13
k10
k10
Two compartmentmodel
Three compartmentmodel
Vi = Volume of central compartment
Vt 2 or 3 = Volume of peripheral compartments
Multicompartment ModelingMulticompartment Modeling
41
Assumptions (Two-Compartment Model)Assumptions (Two-Compartment Model)
• Drug in peripheral compartment (bone, fat, muscle etc.) equilibrates with drug in central compartment
•Plasma, highly perfused organs, extracellular water
• [C] in a given compartment is uniform
• Two-compartment drugs distribute into various tissues at different, first order rates
• Elimination follows a single 1st order rate process only after distribution equilibrium is reached
• Drug in peripheral compartment (bone, fat, muscle etc.) equilibrates with drug in central compartment
•Plasma, highly perfused organs, extracellular water
• [C] in a given compartment is uniform
• Two-compartment drugs distribute into various tissues at different, first order rates
• Elimination follows a single 1st order rate process only after distribution equilibrium is reached
Vi Vt
k12
k21
k10
42
Two-Compartment Model (Mathematical Perspective)Two-Compartment Model (Mathematical Perspective)
• Ct is a bi-exponential decaying function that depends on 2 hybrid constants (A and B), which can be determined graphically, and the distribution () and elimination (β) rate constants
• Ct is a bi-exponential decaying function that depends on 2 hybrid constants (A and B), which can be determined graphically, and the distribution () and elimination (β) rate constants
Ct = A • e -t + B • e –βtCt = A • e -t + B • e –βt
A function of k10, k12 and k21
Because >> than β, this term goes to zero at greater t values
43Clinical Pharmacology and Therapeutics. 1993;53:6-14
2-Compartment Data (Linear Plot)2-Compartment Data (Linear Plot)
0.00
4.00
8.00
12.00
16.00
20.00
0.00 2.00 4.00 6.00 8.00 10.00
Time (hr)
Cp
(m
g/d
L)
Concentration-Time Course of Caffeine IV Bolus
44Clinical Pharmacology and Therapeutics. 1993;53:6-14
2-Compartment Data (Semi-log Plot)2-Compartment Data (Semi-log Plot)
1.00
10.00
100.00
0.00 2.00 4.00 6.00 8.00 10.00
Time (hr)
Cp
(m
g/d
L)
Concentration-Time Course of Caffeine IV Bolus
45
1.00
10.00
100.00
0.00 2.00 4.00 6.00 8.00 10.00
Time (hr)
Cp
(m
g/d
L)
2-Compartment Data (Semi-Log Plot)2-Compartment Data (Semi-Log Plot)
Distribution or Alpha Phase
Elimination or Beta Phase
Slope = β/2.303
Concentration-Time Course of Caffeine IV Bolus
Note the bi-exponential decline in drug concentration
A
B
Slope = /2.303
46
Calculation of Micro-constantsCalculation of Micro-constants
• k21 = • B + β • A
A + B
• k10 = • β
k21
• k12 = + β – k10 – k21
• k21 = • B + β • A
A + B
• k10 = • β
k21
• k12 = + β – k10 – k21
Vi Vt
k12
k21
k10
Note: Micro-constants cannot be calculated by direct means
47
Two-Compartment Elimination Rate ConstantsTwo-Compartment Elimination Rate Constants
• k10 represents elimination from central compartment only• Larger than β
• Not dependent on drug transfer into tissue compartment
• β represents elimination when distribution equilibrium attained• Influenced by drug transfer into deep tissues
• Clinically more useful than k10
• k10 represents elimination from central compartment only• Larger than β
• Not dependent on drug transfer into tissue compartment
• β represents elimination when distribution equilibrium attained• Influenced by drug transfer into deep tissues
• Clinically more useful than k10
48
Initial Concentration (Time = 0)Initial Concentration (Time = 0)
• Answer: The initial concentration at time = 0 is equal to the sum of the intercepts A and B
• Answer: The initial concentration at time = 0 is equal to the sum of the intercepts A and B
Question 1:
Based on the information gathered thus far, what is the drug
concentration at time Zero?
49
Half-LifeHalf-Life
• Compounds demonstrating two compartment kinetics will have t1/2 estimates for each exponential phases
• Distribution half-life
• t ½ Dist = ln2/
• Elimination half-life
• t ½ Elim = ln2/β
• Terminal Half life is the elimination half life for most of drugs
• Compounds demonstrating two compartment kinetics will have t1/2 estimates for each exponential phases
• Distribution half-life
• t ½ Dist = ln2/
• Elimination half-life
• t ½ Elim = ln2/β
• Terminal Half life is the elimination half life for most of drugs
50Clinical Pharmacokinetics Concepts and Applications, Third edition, Lippincott Williams & Wilkins, Media, PA 19063
What is the Elimination Half-Life (Aspirin Vs. Gentamicin)?What is the Elimination Half-Life (Aspirin Vs. Gentamicin)?
• Aspirin• Distribution phase accounts for 31% of the dose
• Elimination phase accounts for 69% of the dose
• Terminal half life is the elimination half-life for aspirin
• Gentamicin• Distribution phase accounts for 98% of the dose
• Elimination phase accounts for 2% of the dose
• Distribution half life is the appropriate half-life for gentamicin
• Aspirin• Distribution phase accounts for 31% of the dose
• Elimination phase accounts for 69% of the dose
• Terminal half life is the elimination half-life for aspirin
• Gentamicin• Distribution phase accounts for 98% of the dose
• Elimination phase accounts for 2% of the dose
• Distribution half life is the appropriate half-life for gentamicin
51
Volume of Distribution (Vd)Volume of Distribution (Vd)
• One compartment model Vd is constant:
• Two compartment model Vd changes with time and reaches a plateau at the distribution equilibrium
• One compartment model Vd is constant:
• Two compartment model Vd changes with time and reaches a plateau at the distribution equilibrium
0
DoseVd
C
0
DoseVd
C
52
Two Compartment Model (Vd vs. Time)Two Compartment Model (Vd vs. Time)
0
5
10
15
20
25
30
35
0 5 10 15 20 25
Time (hr)
Vo
lum
e d
istr
ibu
tio
n
Vi
Vdss
Vt
53
Determination of Vi, Vdss and Vd From Hybrid Constants
Determination of Vi, Vdss and Vd From Hybrid Constants
• Vi = Dose
A + B
• VdSS = Vi [1 + k12]
k21
• VdSS = Dose
β • AUC 0 ∞
• Vi = Dose
A + B
• VdSS = Vi [1 + k12]
k21
• VdSS = Dose
β • AUC 0 ∞
• Vt = Vi k12
k21
• Note that VdSS is a
function of transfer rate constants
• The more extensively a drug distributes (i.e., the higher k12) the larger the volume of distribution
• Vt = Vi k12
k21
• Note that VdSS is a
function of transfer rate constants
• The more extensively a drug distributes (i.e., the higher k12) the larger the volume of distribution
54
Vdss- The Concept Vdss- The Concept
• Vt is mostly influenced by the elimination rate and doesn’t reflect distribution
• Vdss is mostly influenced by distribution
• Volume term of the steady state when a drug is infused at a constant rate
• Lies between Vi and Vt
• Generally, difference between Vdss and Vt is small • Aspirin
• Vdss = 10.4 L, Vt = 10.5 L
• Gentamicin
• Vdss = 345 L, Vt = 56 L
• Substantially eliminated before distribution equilibrium achieved
• Vt is mostly influenced by the elimination rate and doesn’t reflect distribution
• Vdss is mostly influenced by distribution
• Volume term of the steady state when a drug is infused at a constant rate
• Lies between Vi and Vt
• Generally, difference between Vdss and Vt is small • Aspirin
• Vdss = 10.4 L, Vt = 10.5 L
• Gentamicin
• Vdss = 345 L, Vt = 56 L
• Substantially eliminated before distribution equilibrium achieved
55
Loading DosesLoading Doses
• Loading doses are designed to achieve therapeutic concentrations faster
• Loading doses are designed to achieve therapeutic concentrations faster
A: 45 mg/h constant IV infusion
B: Plasma [C]
C: Drug remaining from 530 mg IV loading dose
DL = Cp target • Vd
F
DL = Cp target • Vd
F
56
Two-Compartment Distribution, Loading Doses & Site of ActionTwo-Compartment Distribution, Loading Doses & Site of Action
• Some 2-compartment drugs exert their therapeutic and toxic effects on target organs located in the central compartment• Lidocaine, quinidine, procainamide
• Some 2-compartment drugs exert their therapeutic and toxic effects on target organs located in the central compartment• Lidocaine, quinidine, procainamide
Question 2:How should loading doses for these drugs be handled?
57
Loading Doses for Two-Compartment Drugs Acting in Vi
Loading Doses for Two-Compartment Drugs Acting in Vi
Answer:
Slow administration to allow for drug distribution into Vt
OR…Small bolus doses such that
Cp does not exceed predetermined concentrations
DL = VC • CSS
Answer:
Slow administration to allow for drug distribution into Vt
OR…Small bolus doses such that
Cp does not exceed predetermined concentrations
DL = VC • CSS
58
Two-Compartment Distribution, Loading Doses & Site of ActionTwo-Compartment Distribution, Loading Doses & Site of Action
• Some 2-compartment drugs exert their therapeutic and toxic effects on target organs located in Vt
• Digoxin has a myocardium distribution half-life of 35 min and requires 8 to 12 h to completely distribute
• Some 2-compartment drugs exert their therapeutic and toxic effects on target organs located in Vt
• Digoxin has a myocardium distribution half-life of 35 min and requires 8 to 12 h to completely distribute
Question 3:How should loading doses for these drugs be handled?
59
Loading Doses for Two-Compartment Drugs Acting in Vt
Loading Doses for Two-Compartment Drugs Acting in Vt
Answer:
Quick administration is fine sincethe initially observed high Cps are
not dangerous.These concentrations, however,
cannot be used to predicttherapeutic effects.
DL = VSS • CSS
Answer:
Quick administration is fine sincethe initially observed high Cps are
not dangerous.These concentrations, however,
cannot be used to predicttherapeutic effects.
DL = VSS • CSS
60
Loading Doses: The Case of LidocaineLoading Doses: The Case of Lidocaine
• A: Loading dose + Infusion using Vi (volume of central compartment)
• B: Loading dose + Infusion using VSS
• Doted line: Constant infusion with no loading dose
• Dashed line: Loading dose using Vi, no infusion
• A: Loading dose + Infusion using Vi (volume of central compartment)
• B: Loading dose + Infusion using VSS
• Doted line: Constant infusion with no loading dose
• Dashed line: Loading dose using Vi, no infusion
Seizures
Hypotension
61
TipTip
• If Vdss is unknown, use a value that falls between Vt and Vi
• If Vdss is unknown, use a value that falls between Vt and Vi
62
Estimation of AUCEstimation of AUC
From hybrid constants:
• AUC0∞ = A + B
β
From hybrid constants:
• AUC0∞ = A + B
β
Area t2 t3 = ½ (t3 – t2)(C2 + C3)
AUC by Trapezoidal Method
63
ORGANQ.CA Q.Cv
elimination
Clearance –Two Compartment ModelClearance –Two Compartment Model
• CA = arterial blood concentration; Cv= Venous blood concentration; Q = blood flow
• Clearance = Q(Ca-Cv)
Ca
• CA = arterial blood concentration; Cv= Venous blood concentration; Q = blood flow
• Clearance = Q(Ca-Cv)
Ca
64
Clearance (Two Compartment Model)Clearance (Two Compartment Model)
• Answer: Clearance is model independent. However we need to use different rate constants depending on the choice of volume term
• Example: Cltotal = k10 • Vi
• Answer: Clearance is model independent. However we need to use different rate constants depending on the choice of volume term
• Example: Cltotal = k10 • Vi
Question 4:Clearance (1- compartment Model):
Vd • Kel
Clearance (2- compartment model):?
65
Model-Independent Calculation of ClearanceModel-Independent Calculation of Clearance
• Cl = Dose
AUC 0 ∞
• No modeling consideration needed, but requires accurate measurement of AUC• Early & frequent sampling essential
• Units = Volume/time
• Theoretical volume of blood or plasma completely cleared of drug per unit time
• Cl = Dose
AUC 0 ∞
• No modeling consideration needed, but requires accurate measurement of AUC• Early & frequent sampling essential
• Units = Volume/time
• Theoretical volume of blood or plasma completely cleared of drug per unit time
66
One vs. Two Compartment DilemmaOne vs. Two Compartment Dilemma
• Distribution phase may be missed entirely if blood is sampled too late or at wide intervals after drug administration
• Distribution phase may be missed entirely if blood is sampled too late or at wide intervals after drug administration
67
Use of One Compartment Modeling for Two-Compartment DrugsUse of One Compartment Modeling for Two-Compartment Drugs
• If no concentration-time data points lie above back-extrapolated terminal line (semilog paper), assume one-compartment kinetics
• One-compartment modeling can be used in place of two-compartment modeling provided:
• Duration of distribution is small compared with elimination half-life
• Elimination is minimal during distribution• Referred to as “non-significant” 2-compartment kinetics
• Pharmacokinetic parameters must be computed after distribution is over
• If no concentration-time data points lie above back-extrapolated terminal line (semilog paper), assume one-compartment kinetics
• One-compartment modeling can be used in place of two-compartment modeling provided:
• Duration of distribution is small compared with elimination half-life
• Elimination is minimal during distribution• Referred to as “non-significant” 2-compartment kinetics
• Pharmacokinetic parameters must be computed after distribution is over
68
Tips For Solving the Problem Set
Tips For Solving the Problem Set
69
• Plot Cp against time on semilog paper
• Extrapolate terminal phase to t = 0• Intercept = B
• Slope = /2.303
• Read at least 3 extrapolated [C]s during distribution
• Calculate residual [C]s• Measured – extrapolated
• Plot residuals against time (semilog paper)• Intercept of “feathered” line = A
• Slope = /2.303
• Plot Cp against time on semilog paper
• Extrapolate terminal phase to t = 0• Intercept = B
• Slope = /2.303
• Read at least 3 extrapolated [C]s during distribution
• Calculate residual [C]s• Measured – extrapolated
• Plot residuals against time (semilog paper)• Intercept of “feathered” line = A
• Slope = /2.303